Cosaic raised USD 6 million in a seed extension led by dsm-firmenich Ventures, with a Swiss family office, Kickfund and existing investors including Navus Ventures and Zurich Cantonal Bank participating. The Horgen company will fund regulatory work, production scale-up and industrial trials with major customers as it prepares for market entry.
Formerly Cultivated Biosciences, Cosaic develops yeast-fermentation ingredients that combine texture, stability and other functions in a single component. Its approach aims to simplify formulations that otherwise require several ingredients and additives.
